Jurickson Profar’s career has taken another dramatic and costly turn, and this time the consequences are even more severe. The Atlanta Braves designated hitter has been handed a 162-game suspension after testing positive for performance-enhancing drugs for the second time in his Major League Baseball career. The announcement comes just one year after Profar served an 80-game suspension at the very start of the 2025 season. As a repeat offender under MLB’s Joint Drug Prevention and Treatment Program, the penalty is automatic and unforgiving: a full-season ban.
According to reports, Profar will forfeit the entirety of his $15 million salary for the 2026 season and will be ineligible for postseason play should Atlanta qualify. For a player who signed a three-year, $42 million deal with the Braves in January 2025, the financial and reputational toll is substantial.
A Costly Braves Second Strike
The timing of the suspension intensifies its impact. Profar was scheduled to begin playing for the Netherlands in the World Baseball Classic on the same day the news broke. Instead of representing his country on the international stage, he now faces a year away from professional competition.
When Profar was first suspended last season, he publicly stated that “it is because of my deep love and respect for this game that I would never knowingly do anything to cheat it.” The Braves responded at the time by expressing that they were “surprised and extremely disappointed,” while emphasizing their full support for MLB’s drug prevention program and voicing hope that Profar would learn from the experience. As of now, Profar has not issued a statement regarding this second violation.
He now becomes just the sixth player to receive a 162-game suspension since Major League Baseball increased penalties for repeat offenders in 2014, underscoring how rare and serious a second violation has become under the league’s current framework.
Braves Forced Into Another Reset
For Atlanta, the fallout is immediate and significant. The Braves were already navigating spring training without starting pitchers Spencer Schwellenbach and Hurston Waldrep due to elbow injuries. Profar was expected to play a central role in the lineup as he prepared for what would have been his first full season with the club.
After undergoing sports hernia surgery during the offseason, the 33-year-old was set to shift permanently into the designated hitter role and move toward the top of the batting order. His return to form late last season had given the Braves reason for optimism. After debuting in July following his first suspension, Profar produced a .245/.353/.434 slash line with 14 home runs, stabilizing the lineup during the stretch run.
Now, manager Walt Weiss must rethink those plans entirely, recalibrating both roster construction and offensive strategy without a player who was expected to be a steady presence.
A Career of Promise, Interrupted Again
Profar’s trajectory has always carried a sense of unfinished potential. Once ranked as baseball’s No. 1 overall prospect, he debuted at just 19 years old with the Texas Rangers and was widely viewed as a cornerstone talent. Yet injuries repeatedly stalled his ascent, forcing him onto the injured list for extended stretches during critical developmental years.
The second suspension now adds another defining chapter to that story. When Profar becomes eligible to return in time for the 2027 season, he will have one year remaining on his contract and will be set to earn $15 million.
Whether he can reclaim his footing and restore trust within the clubhouse and across the league will define the final stretch of a career that has veered sharply from early expectations.
